Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
For MASLD or early MASH, incorporating GLP-1RAs may bridge metabolic and hepatology care and slow disease progression
The Safety Note: Sudden Symptoms Before we proceed, it is important to state that while GLP-1s are generally well-tolerated, they can cause side effects
During the first 2 to 4 weeks, patients primarily notice appetite reduction and smaller portion sizes rather than major weight changes
Some patients report an intense psychological rebound of preoccupation with food, leading to: This can be distressing for those with a history of eating disorders or food addiction and may require nutritional counseling
US$ 21.54
US$ 25.05
US$ 28.30
US$ 20.50
